Single low dose primaquine to block the transmission of Plasmodium falciparum—proposed stand-alone and ACT-adapted regimens
Abstract Background Despite the 2012 WHO recommendation to add single low dose primaquine (SLDPQ, 0.25 mg/kg body weight) to artemisinin-based combination treatments (ACTs) for blocking the transmission of artemisinin-resistant Plasmodium falciparum, there are currently no weight-based regimens foun...
Saved in:
| Main Authors: | Walter R. J. Taylor, Peter Olupot-Olupot, Marie A. Onyamboko, Natenapa Chimjinda, Chiraporn Taya, Julie Nguyen Ngoc Pouplin, Thomas N. Williams, Kathryn Maitland, Caterina A. Fanello, Nicholas P. J. Day, Joel Tarning, Nicholas J. White, Mavuto Mukaka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12916-025-04153-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High daily dose Short COurse PrimaquinE after G6PD testing for the radical cure of Plasmodium vivax malaria in Indonesia and Papua New Guinea: the SCOPE implementation study protocol
by: SCOPE Study Group
Published: (2025-07-01) -
Post-treatment transmissibility of Plasmodium falciparum infections: an observational cohort study
by: Kassahun Habtamu, et al.
Published: (2025-03-01) -
Effect of low-dose primaquine treatment on Plasmodium vivax recurrence and transmission-blocking activity in southwest Ethiopia: a longitudinal cohort study
by: Hallelujah Getachew, et al.
Published: (2025-04-01) -
Efficacy of chloroquine with primaquine for uncomplicated Plasmodium vivax malaria without G6PD testing in Northwest Ethiopia: a one-arm in vivo prospective therapeutic efficacy study
by: Eyob Getu, et al.
Published: (2025-06-01) -
Unmasking hidden risks: A case of primaquine-induced intravascular hemolysis in G-6-PD deficient malaria patient
by: Tanatorn Soravipukuntorn, et al.
Published: (2024-11-01)